RareCyte
Seattle
About RareCyte
RareCyte is a provider of precision biology solutions that delivers platforms and services in both spatial biology and liquid biopsy. It offers tissue-based imaging tools under the Orion Spatial Biology suite, including imaging instruments and panels enabling multiplexed biomarker analysis in a single scan, and supplies rare cell analysis instruments and consumables such as the CyteFinder II imaging systems, CytePicker module, AccuCyte sample preparation, and RarePlex panel kits for circulating tumor cell (CTC) detection and characterization. Additionally, RareCyte extends its offering with precision biology services encompassing custom assay development, clinical trial sample testing, and data analysis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $96.5M
- Last round: Grant (Aug 2025)
- Website: rarecyte.com
- Phone: 2064559097
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/rarecyte-58407 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.